Maraviroc
Hepatotoxicity
- Hepatotoxicity has been reported with use of maraviroc
- Severe rash or evidence of a systemic allergic reactions (e.g., fever, eosinophilia, or elevated IgE) prior to the development of hepatotoxicity may occur.
- Patients with signs or symptoms of hepatitis or allergic reaction following use of maravoic should be evaluated immediately [See Warnings and Precautions in package insert]
Patient Counseling Information
Medication Guides
Package Inserts
Additional Information
Updated January 2018